synthesized by reaction of III with organic and inorganic bases. Compounds possessing antiaggregant
activityBogdanov, A.V.,
Andreeva, O.V.,
Belenok, M.G.,
Voloshina, A.D.,
Enikeeva, K.I.,
Samorodov, A.V.,
Mironov, V.F. (2021) and have a significant antiaggregatory and anticoagulant
activity at the
level of reference drugs
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022)
studies of the antiplatelet, anticoagulant, and antioxidant
activity revealed promising compounds
Khaliullin, F.A.,
Shabalina, Y.V.,
Samorodov, A.V.,
Kamilov, F.K.,
Timirkhanova, G.A.,
Murataev, D.Z. (2018) spectroscopy data. The compounds synthesized here had potentially high antiaggregatory
activity.
Gurevich, K.G.,
Urakov, A.L.,
Khaliullin, F.A.,
Samorodov, A.V.,
Shabalina, Y.V.,
Kamilov, F.K.,
Murataev, D.Z.,
Bashirova, L.I. (2020) -aggregation
activity. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
GUREVICH, K.G.,
URAKOV, A.L.,
KHALIULLIN, F.A.,
SAMORODOV, A.V.,
SHABALINA, Y.V.,
KAMILOV, F.KH.,
MURATAEV, D.Z.,
BASHIROVA, L.I. (2020) -aggregation
activity. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) under high glucose condition, which was mediated by p38MAPK
activation. MD2 knockout or pharmacological